Table 6.
Differences in hypertension-related symptom severity scores between Omega3Q10 and soybean oil groups after the 12-weeks intervention (0 = no symptoms, 5 = most severe)
| Symptom | Group | Symptom score difference (N/%) | Z | P | |||||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | ||||
| Dizziness | Omega3Q10 | 28/58.3 | 16/33.3 | 4/8.3 | 0/0.0 | 0/0.0 | 0/0.0 | 0.795 | 0.427 |
| Soybean oil | 27/55.1 | 12/24.5 | 8/16.3 | 2/4.1 | 0/0.0 | 0/0.0 | |||
| Headache | Omega3Q10 | 46/95.8 | 2/4.2 | 0/0.0 | 0/0.0 | 0/0.0 | 0/0.0 | 3.238 | 0.001 |
| Soybean oil | 35/71.4 | 12/24.5 | 2/4.1 | 0/0.0 | 0/0.0 | 0/0.0 | |||
| Tinitus | Omega3Q10 | 48/100.0 | 0/0.0 | 0/0.0 | 0/0.0 | 0/0.0 | 0/0.0 | 1.732 | 0.083 |
| Soybean oil | 46/93.9 | 1/2.0 | 1/2.1 | 0/0.0 | 1/2.0 | 0/0.0 | |||
| Palpitations & chest tightness | Omega3Q10 | 46/95.8 | 2/4.2 | 0/0.0 | 0/0.0 | 0/0.0 | 0/0.0 | 2.852 | 0.004 |
| Soybean oil | 37/75.5 | 10/20.4 | 1/2.1 | 1/2.0 | 1/2.0 | 0/0.0 | |||
| Other symptoms | Omega3Q10 | 48/100.0 | 0/0.0 | 0/0.0 | 0/0.0 | 0/0.0 | 0/0.0 | <0.001 | 1.000 |
| Soybean oil | 49/100.0 | 0/0.0 | 0/0.0 | 0/0.0 | 0/0.0 | 0/0.0 | |||